An antiviral product is comprised of at least three dosages forms, each of which
has a different release profile, with the Cmax for the antiviral product
being reached in less than about twelve hours. In one embodiment, there is an immediate
release dosage form, as well as two or more delayed release dosage forms, with
each of the dosage forms having a different release profile, wherein each reaches
a Cmax at different times.
